Cargando…

A Randomized Pilot Study of L-Arginine Infusion in Severe Falciparum Malaria: Preliminary Safety, Efficacy and Pharmacokinetics

BACKGROUND: Decreased nitric oxide (NO) and hypoargininemia are associated with severe falciparum malaria and may contribute to severe disease. Intravenous L-arginine increases endothelial NO in moderately-severe malaria (MSM) without adverse effects. The safety, efficacy and pharmacokinetics of L-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Tsin W., Lampah, Daniel A., Rooslamiati, Indri, Gitawati, Retno, Tjitra, Emiliana, Kenangalem, Enny, Price, Ric N., Duffull, Stephen B., Anstey, Nicholas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726665/ https://www.ncbi.nlm.nih.gov/pubmed/23922746 http://dx.doi.org/10.1371/journal.pone.0069587

Ejemplares similares

Safety Profile of L-Arginine Infusion in Moderately Severe Falciparum Malaria
por: Yeo, Tsin W., et al.
Publicado: (2008)

Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malaria
por: Yeo, Tsin W., et al.
Publicado: (2007)

Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome
por: Yeo, Tsin W., et al.
Publicado: (2010)

Correction: Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome
por: Yeo, Tsin W., et al.
Publicado: (2010)

Impaired Systemic Tetrahydrobiopterin Bioavailability and Increased Dihydrobiopterin in Adult Falciparum Malaria: Association with Disease Severity, Impaired Microvascular Function and Increased Endothelial Activation
por: Yeo, Tsin W., et al.
Publicado: (2015)

Coma Associated with Microscopy-Diagnosed Plasmodium vivax: A Prospective Study in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2011)

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2014)

Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia
por: Tjitra, Emiliana, et al.
Publicado: (2008)

Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2015)

L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Ralph, Anna P., et al.
Publicado: (2013)

Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria
por: Yeo, Tsin W, et al.
Publicado: (2019)

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
por: Karyana, Muhammad, et al.
Publicado: (2016)

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
por: Lampah, Daniel A., et al.
Publicado: (2015)

Parasite-Dependent Expansion of TNF Receptor II–Positive Regulatory T Cells with Enhanced Suppressive Activity in Adults with Severe Malaria
por: Minigo, Gabriela, et al.
Publicado: (2009)

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study
por: Pontororing, Gysje J, et al.
Publicado: (2010)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
por: Kenangalem, Enny, et al.
Publicado: (2016)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
por: Douglas, Nicholas M, et al.
Publicado: (2014)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
por: Leonardo, Leo, et al.
Publicado: (2022)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
por: Oyong, Damian A., et al.
Publicado: (2018)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum
por: Karyana, Muhammad, et al.
Publicado: (2008)

Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria
por: Woodberry, Tonia, et al.
Publicado: (2009)

Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
por: Langford, Siobhan, et al.
Publicado: (2015)

Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups
por: Kenangalem, Enny, et al.
Publicado: (2013)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection
por: Kho, Steven, et al.
Publicado: (2016)

High Morbidity during Treatment and Residual Pulmonary Disability in Pulmonary Tuberculosis: Under-Recognised Phenomena
por: Ralph, Anna P., et al.
Publicado: (2013)

Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria
por: Pinzon-Charry, Alberto, et al.
Publicado: (2013)

Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
por: Douglas, Nicholas M., et al.
Publicado: (2013)

Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms
por: Suwanarusk, Rossarin, et al.
Publicado: (2007)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Early and late mortality after malaria in young children in Papua, Indonesia
por: Patriani, Dewi, et al.
Publicado: (2019)

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia
por: Devine, Angela, et al.
Publicado: (2018)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
por: Burdam, Faustina Helena, et al.
Publicado: (2016)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
por: Pava, Zuleima, et al.
Publicado: (2020)

Therapeutic Response to Dihydroartemisinin–Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2018)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia
por: Ratcliff, A., et al.
Publicado: (2007)

Plasmodium falciparum Activates CD16(+) Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria
por: Loughland, Jessica R, et al.
Publicado: (2019)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
por: Pava, Zuleima, et al.
Publicado: (2017)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kgbdfcaeem9nossat4b19sga0g